当前位置:首页 - 行情中心 - 塞力医疗(603716) - 财务分析 - 现金流量表

塞力医疗

(603716)

  

流通市值:53.38亿  总市值:53.38亿
流通股本:2.10亿   总股本:2.10亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金650,973,080352,116,206.852,122,298,647.381,606,333,703.88
  收到其他与经营活动有关的现金4,984,266.743,321,867.528,889,132.482,551,212.7
  经营活动现金流入小计655,957,346.74355,438,074.352,151,187,779.861,608,884,916.58
  购买商品、接受劳务支付的现金529,206,099.99293,467,240.271,599,308,819.541,262,807,874.79
  支付给职工以及为职工支付的现金94,044,729.8251,325,343.64200,940,240.94158,412,642.31
  支付的各项税费44,818,520.3623,300,625.6496,776,204.6178,798,150.68
  支付其他与经营活动有关的现金67,057,041.1937,971,470.98154,567,166.01108,370,108.22
  经营活动现金流出小计735,126,391.36406,064,680.532,051,592,431.11,608,388,776
  经营活动产生的现金流量净额-79,169,044.62-50,626,606.1899,595,348.76496,140.58
二、投资活动产生的现金流量:
  收回投资收到的现金--23,738,626.613,100,000
  取得投资收益收到的现金--143.53445.81
  处置固定资产、无形资产和其他长期资产收回的现金净额95,579.72752.13537,663.01480,946.9
  处置子公司及其他营业单位收到的现金净额37,234,586.3335,234,586.3327,490,297.610,798,954.44
  收到的其他与投资活动有关的现金16,285,848.510,266,00014,626,410.7518,239,609.15
  投资活动现金流入小计53,616,014.5545,501,338.4666,393,141.532,619,956.3
  购建固定资产、无形资产和其他长期资产支付的现金3,755,821.111,204,882.8423,210,163.3413,806,525.26
  投资支付的现金9,891,573-50,857,398.7811,273,398.78
  投资活动现金流出小计13,647,394.111,204,882.8474,067,562.1225,079,924.04
  投资活动产生的现金流量净额39,968,620.4444,296,455.62-7,674,420.627,540,032.26
三、筹资活动产生的现金流量:
  吸收投资收到的现金80,000-1,800,241.31,800,241.3
  其中:子公司吸收少数股东投资收到的现金--1,800,241.3800,241.3
  取得借款收到的现金179,809,209.9932,512,822.1373,989,534.2295,638,539.63
  收到其他与筹资活动有关的现金16,575,10010,000,10081,918,395.3850,311,430.46
  筹资活动现金流入小计196,464,309.9942,512,922.1457,708,170.88347,750,211.39
  偿还债务支付的现金176,030,00042,350,000420,643,542.46192,913,581.03
  分配股利、利润或偿付利息支付的现金8,577,1043,798,913.2559,879,030.2967,406,719.76
  支付其他与筹资活动有关的现金59,068,452.0931,785,651.22125,457,036.45106,794,979.11
  筹资活动现金流出小计243,675,556.0977,934,564.47605,979,609.2367,115,279.9
  筹资活动产生的现金流量净额-47,211,246.1-35,421,642.37-148,271,438.32-19,365,068.51
四、汇率变动对现金及现金等价物的影响--13,256.51.0850.77
五、现金及现金等价物净增加额-86,411,670.28-41,765,049.43-56,350,509.1-11,328,844.9
  加:期初现金及现金等价物余额207,484,483.92207,484,483.92263,834,993.02263,834,993.02
  期末现金及现金等价物余额121,072,813.64165,719,434.49207,484,483.92252,506,148.12
补充资料:
  净利润-51,553,623.86--193,389,577.14-
  资产减值准备372,558.04-25,597,401.25-
  固定资产和投资性房地产折旧14,588,182.57-33,847,927.93-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧14,588,182.57-33,847,927.93-
  无形资产摊销1,488,863.09-2,306,761.14-
  长期待摊费用摊销4,731,255.36-9,856,876.92-
  处置固定资产、无形资产和其他长期资产的损失-835,879.46--7,620,084.92-
  固定资产报废损失51,626.56-1,754,573.05-
  财务费用27,079,468.17-57,681,021.77-
  投资损失-9,736,549.95-65,216,566.55-
  递延所得税-9,292,431.9-29,893,599.35-
  其中:递延所得税资产减少-7,644,071.59-33,781,387.7-
    递延所得税负债增加-1,648,360.31--3,887,788.35-
  存货的减少10,973,308.17-15,441,733.76-
  经营性应收项目的减少5,062,522.84-65,618,595.84-
  经营性应付项目的增加-93,236,566.75-11,430,789-
  现金的期末余额121,072,813.64-207,484,483.92-
  减:现金的期初余额207,484,483.92-263,834,993.02-
  现金及现金等价物的净增加额-86,411,670.28--56,350,509.1-
公告日期2025-08-292025-04-292025-04-292024-10-29
审计意见(境内)标准无保留意见
TOP↑